ClinicalTrials.Veeva

Menu

Chemotherapy With or Without Radiosurgery for Asymptomatic Oligo Brain Metastasis

Samsung Medical Center logo

Samsung Medical Center

Status and phase

Unknown
Phase 3

Conditions

Nonsmall Cell Lung Cancer

Treatments

Radiation: Radiosurgery
Radiation: Observation

Study type

Interventional

Funder types

Other

Identifiers

NCT01301560
2008-05-024

Details and patient eligibility

About

The need of radiosurgery is controversial for asymptomatic oligo brain metastasis for non small cell lung cancer (NSCLC).

Therefore, the investigators do a randomized study comparing overall survival between two groups with or without radiosurgery for asymptomatic oligo brain metastasis before palliative chemotherapy for NSCLC.

Enrollment

176 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Histologically confirmed non-small cell lung cancer with synchronous brain metastases

  2. One to 4 intraparenchymal brain metastases by contrast-enhanced MRI, meeting the following criteria:

    • Well circumscribed tumor(s) with brain edema Grade 0-1
    • Maximum diameter ≤ 3.0 cm
  3. No prior surgical treatment or RT for brain metastases

  4. No leptomeningeal metastases by MRI or cerebrospinal fluid evaluation

  5. Patients without any symptoms or signs from brain metastases (RTOG neurologic functions status of 0)

  6. Age, 18 and over

  7. ECOG performance status 0-1

  8. Written informed consent

Exclusion criteria

  1. severe co-morbid illness and/or active infections
  2. pregnant or lactating women
  3. RTOG neurologic function status of 1~4
  4. Uncontrollable extracranial metastases

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

176 participants in 2 patient groups

Radiosurgery arm
Experimental group
Description:
Radiosurgery before palliative chemotherapy
Treatment:
Radiation: Radiosurgery
Observation arm
No Intervention group
Description:
No radiotherapy or local treatment until specific symptoms or sign developed
Treatment:
Radiation: Observation

Trial contacts and locations

1

Loading...

Central trial contact

Myung-Ju Ahn, Pf

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems